2Bech GJ,De Bruyne B,Pijls NH,et al. Fractitnal flow reserve to determine the approprtateness of angioplasty in woletate coronary steuosis:a randomized trial[ J ]. Circulation, 2001,103 ( 24 ) :2928.
3Boden WE, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease [ J ]. N Engl J Med 2007, 356(15) :1503.
4Maseri A. The variable chronic atherosclerotic background. In:Maseri A. Ischemic heart disease. Ist ed. New York, NY:Churchill Livingstone, 1995,193.
5Mc Gill HC Jr, Mc Mahan CA ,Zie S Ke AW ,et al. Associations of Coronary Heart Disease Risk Factors With the Intermediate Lesion of Atherosclerosis in Youth [ J]. ArteriosclerThromb. Vasc. Biol. 2000,20 ; 1998.
6Hong MK,Mintz GS, Lee CW, et al. Intravascular ultrasound predictors of angiographic restenosis after sirolimus - eluting stent implantation [ J]. EurHeart J ,2006,27 ( 11 ) : 1305.
7Ozdemir, Yazici,Turkoglu, et al. Metoprolol Does Not Effect Myocardial Fractional Flow Reserve in Patients With Intermediate Coronary Stenoses. Int Heart J,2007,48(4) :477.
8Rieber J, Jung P, Schiele TM, eta. 1 Safety of FFR - based treatmenit strategies :the Mumich experience [ J ]. Z Kardiol,2002, 91 ( suppl3 ) : 115.
9Bartunek J, van Schuerbeeck E, de Bruyne B. Comparison of exercise electrocardiography and dobutamine echocardiography with invasively assessed myocardial fractional flow reserve in evaluation of severity ofcoronary arterial narrowing[ J]. Am J Cardio, 1997,79 (4) : 478.
10Heller LI, Cates C, Popma J, et al. Intracoronary doppler assessment of moderate coronary artery disease. Comparison with 201TI imaging and coronary angioplasty. Circulation, 1997,96 ( 2 ) :484.
